The first world report of botulinum A toxin injection for status migrainosus

Journal of the Medical Association of Thailand

Volumn 84, Issue 8, 2001, Pages 1199-1203

  Poungvarin, Niphon ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Botulinum A toxin; Status migrainosus

Indexed keywords

ACETYLSALICYLIC ACID; BOTULINUM TOXIN A; DIAZEPAM; ERGOTAMINE; MEFENAMIC ACID; PARACETAMOL;

ACUPUNCTURE; ADULT; ARTICLE; CASE REPORT; DRUG EFFICACY; HEADACHE; HUMAN; MALE; MIGRAINE; TREATMENT OUTCOME;

ACUPUNCTURE POINTS; BOTULINUM TOXIN TYPE A; HUMANS; INJECTIONS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PAIN MEASUREMENT; THAILAND; TIME FACTORS; TREATMENT OUTCOME;

EID: 0035694613     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Scher AI, Stewart WF, Lipton RB. Migraine and headache : A meta-analytic approach. In: Crombie IK, ed. Epidemiology of pain. Seattle : IASP Press, 1999: 59-70.
2. Silberstein SD, Lipton RB, Goadsby PJ. Headache in clinical practice. Oxford : ISCS Medical Media, 1998.
3. Lipton RB, Diamond S, Reed M, et al. American Migraine Study II: Prevelence, burden and health care utilization for migraine in the United States. Headache 2000; 40: 427 (Abstract).
4. Pryse-Phillips W, Findlay H, Tugwell P, Edmeads J, Murray TJ, Nelson RF. A Canadian population survey on the clinical, epidemiologic and societal impact of migraine and tension-type headache. Can J Neurol Sci 1992; 19: 333-9.
5. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8 (Suppl 7): 19-28.
6. Cough JR, Diamond S. Status migrainosus : Causative and therapeutic aspects. Headache 1983; 23: 94-101.
7. Blau JN. Ed. Migraine. Clinical, therapeutic, conceptual and research aspects. London : Chapman and Hall, 1987: 201.
8. Callaham M, Raskin N. A controlled study of dihydroergotamine in the treatment of acute migraine headache. Headache 1986; 26: 168-71.
9. Jones J, Sklar D, Dougherty J, White W. Randomized double-blind trial of intravenous prochlorpromazine for the treatment of acute headache. JAMA 1989; 261: 1174-85.
10. Lane PL, Ross R. Intravenous chlorpromazinepreliminary results in acute migraine. Headache 1985; 25: 302-4.
11. Saadah H. Abortive headache therapy in the office with intravenous dihydroergotamine plus prochlorperazine. Headache 1993; 32: 143-6.
12. Raskin NH. Treatment of status migrainosus : The American experience. Headache 1990; 30 (Suppl 2): 550-3.
13. Lane PL, McLellan BA, Baggoley CJ. Comparative efficacy of chlorpromazine and meperidine with dimenhydrinate in migraine headache. Ann Emerg Med 1989; 18: 260-5.
14. Gallagher MR. Emergency treatment of intractable migraine. Headache 1986; 26: 74-5.
15. Reutens DC, Fatovich DM, Stewart-Wynne EG, Prentice DA. Is intravenous lidocaine clinically effective in acute migraine? Cephalalgia 1991; 11: 245-7.
16. Jauslin P, Goadsby PJ, Lance JW. The hospital management of severe migrainous headache. Headache 1991; 31: 658-60.
17. Goadsby PJ, Zagami AS, Donnan GA, et al. Oral sumatriptan in acute migraine. Lancet 1991; 338: 782-3.
18. The Subcutaneous Sumatriptan International Study Group. Treatment of migraine attacks with sumatriptan. N Engl J Med 1991; 325: 316-21.
19. Poungvarin N. Prevalence of dystonia and occupational cramps in Thailand. In: Kimura J, Shibasaki H, eds. Recent advances in clinical neurophysiology. Amsterdam: Elsevier, 1996: 921-32.
20. Poungvarin N, Devahastin V, Viriyavejakul A. Treatment of various movement disorders with botulinum A toxin injection: An experience of 900 patients. J Med Assoc Thai 1996; 78: 281-8.
21. Poungvarin N, Viriyavejakul A. Botulinum A toxin treatment in spasmodic torticollis : Reports of 56 patients. J Med Assoc Thai 1994; 77: 464-70.
22. Poungvarin N. Writer's cramp : The experience with botulinum toxin injection in 25 patients. J Med Assoc Thai 1991; 74: 239-47.
23. Poungvarin N, Devahastin V, Chaisevikul R, Prayoonwiwat N, Viriyavejakul A. Botulinum A toxin treatment for blepharospasm and Meige syndrome: Report of 100 patients. J Med Assoc Thai 1997; 80: 1-8.
24. Poungvarin N, Viriyavejakul A, Komoltri C. Placebo-controlled double-blind cross-over study of botulinum A toxin in hemifacial spasm. Parkin Related Disord 1995; 1: 85-8.
25. Poungvarin N, Viriyavejakul A. Two hundred and fifty patients with hemifacial spasm treated with botulinum toxin injection. J Med Assoc Thai 1992; 75: 199-203.
26. Poungvarin N, Viriyavejakul A. Two hundred and fifty patients with hemifacial spasm treated with botulinum toxin (Abstract). Mov Disord 1990: 6 (Suppl 1): 67.
27. Poungvarin N, Vachalathiti R. Botulinum treatment for post-stroke spasticity : Low dose regimen (Abstract). Eur J Neurol 1996; 3 (Suppl 2): 23.
28. Viriyavejakul A, Vachalathiti R, Poungvarin N. Botulinim treatment for post-stroke spasticity : Low dose regime. J Med Assoc Thai 1998; 81: 413-9.
29. Simpson DM, Alexander DN, O'Brien CF, et al. Botulinum toxin type A in the treatment of upper extremity spasticity : A randomized, double-blind, placebo-controlled trial. Neurology 1996; 46: 1306-10.
30. Snow BJ, Tsui JK, Bhatt MH, Varelas M, Hashimoto SA, Calne DB. Treatment of spasticity with botulinum toxin : A double-blind study. Ann Neurol 1990; 28: 512-5.
31. Maria G, Cassetta E, Gui D, Brisinda G, Bentivoglio AR, Albanese A. A comparison of botulinum toxin and saline for the treatment of chronic anal fissure. N Engl J Med 1998; 338: 217-20.
32. Annese V, Basciani M, Borrelli O, Leandro G, Simone P, Andriulli A. Intrasphincteric injection of botulinum toxin is effective in long-term treatment of esophageal achalasia. Muscle Nerve 1998; 21: 1540-2.
33. Naumann M, Flachenecker P, Brocker EB, Toyka KV, Reiners K. Botulinum toxin for palmar hyperhidrosis. Lancet 1997; 349: 252.
34. Knusel B, Grant M, Loesser JD. Intramuscular injection of botulinum toxin type A (BOTOX) in chronic low back pain associated with muscle spasm. Poster presented at The American Pain Society Meeting; November 1998; San Diego, California. Poster number 672.
35. Moy RL. Why devote an issue to botulinum toxin? Special issue. Denervation techniques for facial rejuvenation. Dermat Surg 1998; 24: 1167-254.
36. Binder W, Brin MF, Blitzer A, Schenrock L, Diamond B. Botulinum toxin type A (BTX-A) for migraine : An open label assessment (Abstract). Mov Disord 1998; 13 (Suppl 2): 241.
37. Silberstein S, Methew N, Saper J, Jenkins S; for the BOTOX Migraine Clinical Research Group. Botulinum toxin type A as a migraine preventive treatment. Headache 2000; 40: 445-50.
38. Schulte-Mattler WJ, Wieser T, Zierz S. Treatment of tension-type headache with botulinum toxin : A pilot study. Eur J Med Res 1999; 4: 183-6.
39. Smuts JA, Baker MK, Smuts M, Stassen JMR, Rossouw E, Barnard PWA. Prophylactic treatment of chronic tension-type headache using botulinum toxin type A. Eur J Neurol 1999; 6 (Suppl 4): S99-S102.
40. Rollnik JD, Tanneberger O, Schubert M, Schneider U, Dengler R. Treatment of tension-type headache with botulinum toxin type A : A double-blind, placebo-controlled study. Headache 2000; 40: 300-5.
41. Poungvarin N, Prayoonwiwat N, Senanarong V, Nilanont Y, Danchaivijitr C. Treatment of headache with botulinum toxin A injection : An open label study of 21 patients. Intern Med J Thai 2001; 17: 105-10.